MyFinsight
Home
Blog
About
Back
Income Statement
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)
source: myfinsight.com
Net loss
attributable to common...
-$9,238K
(33.77%↑ Y/Y)
Interest income
$382K
(-54.25%↓ Y/Y)
Other income
(expense), net
$1K
(200.00%↑ Y/Y)
Net loss
-$9,232K
(33.79%↑ Y/Y)
Preferred stock dividend
payable on series a...
$6K
(0.00%↑ Y/Y)
Total other income
(expense), net
$383K
(-54.08%↓ Y/Y)
Loss from operations
-$9,615K
(34.93%↑ Y/Y)
Royalty revenues
$104K
(-14.05%↓ Y/Y)
Total operating
expenses
$9,719K
(-34.76%↓ Y/Y)
Research and development
$5,915K
(-48.92%↓ Y/Y)
Selling, general and
administrative
$3,804K
(14.65%↑ Y/Y)
Back